US2018092952A1PendingUtilityA1

Anti-aging composition comprising a plant extract

Assignee: IDUNN TECHPriority: May 5, 2015Filed: May 5, 2016Published: Apr 5, 2018
Est. expiryMay 5, 2035(~8.8 yrs left)· nominal 20-yr term from priority
A61P 43/00A61K 31/201A61K 8/43A61K 8/365A61K 36/16A61K 8/9771A61K 36/23A61K 36/76A61K 36/71A61K 36/84A61K 31/132A61K 31/155A61K 2800/78A61K 8/347A61K 2800/5922A61K 8/44A61K 8/41A61Q 19/08A61K 8/9789A61K 36/185A61K 31/05
25
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present description relates to an anti-aging composition comprising at least one plant extract. The composition can comprise at least two different anti-aging agents, wherein one the anti-aging agent is a plant extract. The combination of two anti-aging agents has a superior effect on regulating longevity compared to the use of one anti-aging agent. The plant extract is preferably selected from the group consisting of a Black cohosh extract, a Valerian extract, a Ginkgo biloba extract, a Celery seed extract, a White willow extract and a Passion flower extract.

Claims

exact text as granted — not AI-modified
1 . An anti-aging composition comprising at least two different anti-aging agents, wherein said at least two anti-aging agents are two different plant extracts or one plant extract and a second anti-aging agent, wherein the plant extract is at least one of a Black cohosh extract, a Valerian extract, a  Ginkgo biloba  extract, a Celery seed extract, a White willow extract and a Passion flower extract, and wherein the at least two anti-aging agents have an superior effect on regulating longevity compared to one anti-aging agent. 
     
     
         2 . The composition of  claim 1 , wherein the second anti-aging agent is resveratrol, metformin, myriocin, or spermidine. 
     
     
         3 . The composition of  claim 1  or  2 , wherein the at least two anti-aging agents modulate at least two pathways that regulate longevity. 
     
     
         4 . The composition of  claim 3 , wherein said pathways are TORC1, cAMP/PKA, PKH1/2, SNF1/AMPK or ATG pathways. 
     
     
         5 . An anti-aging composition comprising at least one plant extract selected from the group consisting of a Black cohosh extract, a Valerian extract, a  Ginkgo biloba  extract, a Celery seed extract, a White willow extract and a Passion flower extract, and a carrier. 
     
     
         6 . The anti-aging composition of  claim 5 , said composition comprising a Black cohosh extract, a Valerian extract, a  Ginkgo biloba  extract, a Celery seed extract, a White willow extract and a Passion flower extract. 
     
     
         7 . The anti-aging composition of  claim 5 , said composition further comprising resveratrol, metformin, myriocin, or spermidine. 
     
     
         8 . The anti-aging composition of  claim 7 , comprising a Black Cohosh extract and Spermidine 
     
     
         9 . The anti-aging composition of  claim 7 , comprising a Valerian extract with Resveratrol, metformin, myriocin or Spermidine. 
     
     
         10 . The anti-aging composition of  claim 7 , comprising a passion flower extract and resveratrol, metformin, myriocin, or spermidine. 
     
     
         11 . The anti-aging composition of  claim 7 , comprising a  Ginkgo biloba  extract and myriocin or spermidine. 
     
     
         12 . The anti-aging composition of  claim 7 , comprising a Celery seed extract and Resveratrol, metformin or myriocin. 
     
     
         13 . The anti-aging composition of  claim 7 , comprising a White willow extract and Resveratrol, metformin, myriocin or Spermidine. 
     
     
         14 . The anti-aging composition of  claim 5 , wherein said composition delays the onset and progression of age-related disorders. 
     
     
         15 . The anti-aging composition of  claim 14 , wherein said age-related disorders are cardiovascular disorders, glycemic disorders, neurodegenerative disorders or osteoporosis disorders. 
     
     
         16 . The anti-aging composition of  claim 15 , formulated as a cosmetic composition, a dermatological composition, a nutraceutical composition or a pharmaceutical composition. 
     
     
         17 .- 18 . (canceled) 
     
     
         19 . A method of prolonging longevity of a subject comprising administering to said subject an effective amount of the composition of  claim 1  or  5 . 
     
     
         20 . The method of  claim 19 , wherein the subject is a human, a mice or a nematode.

Join the waitlist — get patent alerts

Track US2018092952A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.